Antikythera_Mechanism

OGN Harmonic: Monthly Deep-Crab

Long
NYSE:OGN   Organon & Co.
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. OGN has a moderate quantitative fundamental score (Greater than 5) with good analyst prospects (Buy and Hold ratings). Furthermore, OGN has a minor dividend pay out @ 0.56 per share/year (2.3%). Therefore, this OGN long play has moderate value at this price-level (24.72).

In this idea, we have a deep-crab pattern reversal and two price targets. I set the stop-loss for 3.32%; however, I'd consider carefully averaging into a position on this trade, if price goes below the stop (I don't expect it to). Once the 0.382 target is acquired, I will sell half of my position and set the stop-loss to trail the position by the 'Average True Range'. Once price has reached the 0.618 target, I will sell the other half of my position. The first target nets 18.2% and the second target nets 34.1%. Averaging these percentage gains out and adding for the dividend (I expect to hold this for at least half-a-year), one would profit approximately 27.2% of their original investment.

Good luck and trade safely!
Comment:
Price touched off the fair value gap, expecting at least a 50% pull back at minimum.
Comment:
Price returned to the order-block for a perfect re-entry. Should have been watching this one!!!
Comment:
I have re-analyzed this stock and, after hitting our targets respectively, there is a better entry lower than the one pictured here. I will post the new analysis and re-entry later. GL and trade safely!
Comment:
Here's the new entry ~

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.